55P Clinicopathological and molecular changes induced by neoadjuvant therapy (NAT) in hormone receptor-positive (HR+)/HER2-low vs HER2 0 breast cancer (BC)
Titel:
55P Clinicopathological and molecular changes induced by neoadjuvant therapy (NAT) in hormone receptor-positive (HR+)/HER2-low vs HER2 0 breast cancer (BC)
Auteur:
Schettini, F. Pascual, T. Ghiglione, L. Brasó-Maristany, F. Martínez-Sáez, O. Conte, B. Cebrecos, I. Mension, E. Ganau, S. Torres, E. Sanfeliu Gonzalez-Farre, B. Jares, P. Vidal-Siscart, S. Mollá, M. Adamo, B. Losada, M.J. Vidal Munoz, M. Prat, A.